Evidence map›Paper›PMID 32178628›Full record

ArticleBMC gastroenterology2020

Impact of preoperative fecal short chain fatty acids on postoperative infectious complications in esophageal cancer patients.

Masaaki Motoori, Koji Tanaka, Keijiro Sugimura, Hiroshi Miyata, Takuro Saito, Yasuhiro Miyazaki, Kazumasa Fujitani, Yukiko Kado, Takashi Asahara, Masahiko Yano

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Masaaki MotooriDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan. mmotoori@gh.opho.jp.
Koji TanakaDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan.
Keijiro SugimuraDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan.
Hiroshi MiyataDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan.
Takuro SaitoDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan.
Yasuhiro MiyazakiDepartment of Surgery, Osaka General Medical Center, 3-1-56 Bandai-higashi, Osaka, 558-8558, Japan.
Kazumasa FujitaniDepartment of Surgery, Osaka General Medical Center, 3-1-56 Bandai-higashi, Osaka, 558-8558, Japan.
Yukiko KadoYakult Central Institute, 1796 Yaho, Kunitachi, Tokyo, 186-8650, Japan.
Takashi AsaharaYakult Central Institute, 1796 Yaho, Kunitachi, Tokyo, 186-8650, Japan.
Masahiko YanoDepartment of Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, Chuo-ku, 541-8567, Japan.
Osaka Medical Center for Cancer and Cardiovascular Diseases · JPOsaka University · JPYakult Central Institute · JPOsaka City General Hospital · JPOsaka Prefectural Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe intestinal epithelial barrier allows absorption of dietary nutrients and prevents passage of pathogens and toxins into the body. Severe insults have a negative impact on the intestinal environment, which may decrease intestinal barrier function and cause bacterial translocation. Bacterial translocation, which can cause infectious complications, is defined as the passage of microbes from the gastrointestinal tract across the mucosal barrier to extraintestinal sites. The aim of this study was to investigate the correlation between concentrations of preoperative fecal organic acids and the occurrence of postoperative infectious complications in patients with esophageal cancer.

methodsFifty-five patients with esophageal cancer who underwent esophagectomy were enrolled in this study. Perioperative synbiotics were administered to all patients. Perioperative clinical characteristics and concentrations of preoperative fecal organic acids were compared between patients with and without postoperative infectious complications.

resultsPostoperative infectious complications occurred in 10 patients. In patients with complications, the concentrations of acetic acid and propionic acid were significantly lower than in patients without complications (p = 0.044 and 0.032, respectively). The concentration of butyric acid was nonsignificantly lower in patients with complications, while the concentration of lactic acid was nonsignificantly higher. The calculated gap between the concentrations of fecal acetic acid plus propionic acid plus butyric acid minus lactic acid was significantly lower in patients with complications. Multivariate analysis revealed that a low gap between acetic acid plus propionic acid plus butyric acid minus lactic acid was an independent risk factor for postoperative infectious complications (p = 0.027).

conclusionsPreoperative fecal concentrations of organic acids had a clinically important impact on the occurrence of postoperative infectious complications in patients with esophageal cancer. To reduce postoperative infectious complications, it may be useful to modulate the intestinal environment and maintain concentrations of fecal organic acids before surgery.

Indexed as

Postoperative ComplicationsAdultAgedEsophageal NeoplasmsEsophagectomyFatty Acids, VolatileFecesFemaleHumansInfectionsMaleMiddle AgedPreoperative PeriodRisk FactorsFatty Acids, VolatileEsophageal cancerEsophagectomyIntestinal environmentOrganic acidsPostoperative complications

Identifiers

PMID32178628
PMCPMC7075004
OpenAlexW3011843689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.